Showing results (231-240 of 324) with videos related to

Sort By:
Pageof 33
International Journal of Molecular Sciences|June 10, 2022
Isogenic GAA-KO Murine Muscle Cell Lines Mimicking Severe Pompe Mutations as Preclinical Models for the Screening of Potential Gene Therapy StrategiesAraceli Aguilar-González, Juan Elías González-Correa, Eliana Barriocanal-Casado, et al.
Scientific Reports|February 28, 2024
Sequential administration of paricalcitol followed by IL-17 blockade for progressive refractory IgA nephropathy patientsMiguel G Uriol-Rivera, Aina Obrador-Mulet, Maria Rosa Juliá, et al.
Journal of Clinical Medicine|June 10, 2023
Simultaneous Surgical Approach with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients with Concurrent Peritoneal and Liver Metastases of Colon Cancer OriginRafael Morales-Soriano, Cristina Pineño-Flores, José Miguel Morón-Canis, et al.
Targeted Oncology|August 2, 2021
Cabozantinib in Pretreated Patients with Metastatic Renal Cell Carcinoma with Sarcomatoid Differentiation: A Real-World StudyMatteo Santoni, Francesco Massari, Enrique Grande, et al.
Expert Opinion on Pharmacotherapy|February 4, 2026
Belzutifan monotherapy and combination therapies in renal cell carcinoma: a clinical trial perspective from the ARON working groupConcetta Calabrò, Francesco Ciccimarra, Alessandro Rizzo, et al.
The International Journal of Behavioral Nutrition and Physical Activity|February 28, 2018
Development and reliability of a streetscape observation instrument for international use: MAPS-globalKelli L Cain, Carrie M Geremia, Terry L Conway, et al.
The American Journal of Gastroenterology|March 17, 2018
Helicobacter pylori infection does not protect against eosinophilic esophagitis: results from a large multicenter case-control studyJavier Molina-Infante, Carolina Gutierrez-Junquera, Edoardo Savarino, et al.
Gastroenterology|March 30, 2019
Efficacy of Budesonide Orodispersible Tablets as Induction Therapy for Eosinophilic Esophagitis in a Randomized Placebo-Controlled TrialAlfredo J Lucendo, Stephan Miehlke, Christoph Schlag, et al.
The Oncologist|February 12, 2020
The PALBONET Trial: A Phase II Study of Palbociclib in Metastatic Grade 1 and 2 Pancreatic Neuroendocrine Tumors (GETNE-1407)Enrique Grande, Alex Teulé, Teresa Alonso-Gordoa, et al.
Cities (London, England)|June 1, 2026
Evaluating the performance of spatial indicators of destination accessibility for physical activity research: a comparative international analysisEster Cerin, Marc A Adams, Terry L Conway, et al.
Pageof 33